Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Operating Margin (2019 - 2025)

Korro Bio's Operating Margin history spans 6 years, with the latest figure at 3635.37% for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 137439.0% year-over-year to 3635.37%, compared with a TTM value of 383.14% through Dec 2025, up 38846.0%, and an annual FY2025 reading of 383.14%, up 38846.0% over the prior year.
  • Operating Margin for Q4 2025 was 3635.37% at Korro Bio, up from 1764.86% in the prior quarter.
  • The five-year high for Operating Margin was 7072.54% in Q1 2023, with the low at 1863.15% in Q2 2025.
  • Average Operating Margin over 4 years is 967.47%, with a median of 309.97% recorded in 2021.
  • Year-over-year, Operating Margin crashed -35644bps in 2021 and then surged 137439bps in 2025.
  • Tracing KRRO's Operating Margin over 4 years: stood at 185.65% in 2021, then surged by 3910bps to 7072.54% in 2023, then crashed by -68bps to 2260.99% in 2024, then surged by 61bps to 3635.37% in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Operating Margin are 3635.37% (Q4 2025), 1764.86% (Q3 2025), and 1863.15% (Q2 2025).